Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

pH Pharma

pH Pharma
2015 FOUNDED
PRIVATE STATUS
Series B LATEST DEAL TYPE
3 INVESTORS
Description

Developer of pharmaceutical drugs intended to provide treatment of various chronic diseases. The company develops Rho Kinase inhibitor for the treatment of normal tension glaucoma without conjunctival congestion and neutrophil elastase inhibitor that neutralizes the physiologically active form of the target enzyme in liver diseases, enabling medical practitioners to treat patients suffering from glaucoma and Nonalcoholic fatty liver disease easily.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • The 50th floor of Jongno 1-ga, Jongno-gu
  • The 9th floor, The Twin Towers
  • Seoul
  • South Korea

+82 00-0000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore pH Pharma’s full profile, request a free trial.

pH Pharma Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series B) 01-Jan-2018 Completed Generating Revenue
2. Early Stage VC (Series A) 01-Apr-2016 Completed Generating Revenue
1. Accelerator/Incubator 01-Jan-2015 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

pH Pharma Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 15-Sep-2016 00000 00000 00 00000 Personal Products
Rezolute 29-Jun-2016 PIPE 0000 Biotechnology 0000000 000 00.0
To view this company’s complete investment and acquisition history, request access »

pH Pharma Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
000000000 15-Sep-2016 00000 00000 00 00000 Completed
  • 00 000000
To view this company’s complete exits history, request access »

pH Pharma Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Red Badge Management Venture Capital Minority 000 0000 000000 0
SBI Investment Korea Company Venture Capital Minority 000 0000 000000 0
MBC BioLabs Accelerator/Incubator Minority 000 0000 000000 0

pH Pharma Executive Team (5)

Name Title Board
Seat
Contact
Info
Hoyoung Huh Ph.D Founder, Co-Chief Executive Officer & Chairman
Jae Kim Ph.D Co-Chief Executive Officer & Board Member
Previn Brito Director, Finance
Jaesoon Kim Vice President & Board Member

1 Former Executive

You’re viewing 4 of 5 executives. Get the full list »

pH Pharma Board Members (7)

Name Representing Role Since Contact
Info
Hoyoung Huh Ph.D pH Pharma Founder, Co-Chief Executive Officer & Chairman 000 0000
Jae Kim Ph.D pH Pharma Co-Chief Executive Officer & Board Member 000 0000
Jaesoon Kim pH Pharma Vice President & Board Member 000 0000
Jungmin Jo pH Pharma Board Member 000 0000
Kim Jin Self Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »